Related Experiment Videos
Role of endothelial dysfunction in coronary artery disease and implications for therapy
1Cardiac Catheterization Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Insights
Lowering cholesterol improves endothelial function, reducing risks for acute coronary syndromes and myocardial ischemia in atherosclerosis patients. This therapy is crucial for managing coronary artery disease.
Area of Science:
- Cardiovascular Biology
- Endothelial Function
- Atherosclerosis Pathophysiology
Background:
- Atherosclerosis involves modified LDL accumulation, inflammation, and reduced nitric oxide, leading to endothelial dysfunction and plaque instability.
- Endothelial cells are critical in modulating inflammation and vasomotor tone, influencing coronary artery disease progression.
- Activated endothelial cells promote leukocyte adhesion and matrix metalloproteinase production, contributing to atherosclerotic lesion vulnerability.
Purpose of the Study:
- To investigate the role of endothelial dysfunction in atherosclerosis and its clinical manifestations.
- To explore the impact of cholesterol reduction on endothelial function and cardiovascular outcomes.
- To establish improving endothelial function as a therapeutic goal in coronary artery disease management.
Main Methods:
- Review of studies examining cellular changes in the arterial wall during atherosclerosis.
- Analysis of the relationship between endothelial cell activation, inflammation, and plaque stability.
- Evaluation of the effects of lipid-lowering therapies on endothelial function and clinical events.
Main Results:
- Atherosclerosis is characterized by endothelial vasomotor dysfunction and reduced nitric oxide bioavailability.
- Endothelial activation facilitates leukocyte infiltration and the production of enzymes that destabilize atherosclerotic plaques.
- Lowering serum total and LDL cholesterol has been shown to reverse endothelial dysfunction, reduce myocardial ischemia, and decrease the risk of acute coronary syndromes.
Conclusions:
- Endothelial dysfunction is a key component of atherosclerosis and contributes to myocardial ischemia.
- Improving endothelial function, particularly through cholesterol reduction, is a vital therapeutic strategy for coronary artery disease.
- Therapeutic interventions aimed at enhancing endothelial function should be prioritized in managing patients with atherosclerosis.
Abstract:
Atherosclerosis is a complex process that is characterized by the accumulation of modified low-density lipoprotein (LDL), local inflammatory and immune responses, and reduced nitric oxide bioavailability within the arterial wall. These cellular changes lead to endothelial vasomotor dysfunction, plaque instability, and the development of clinical events such as stable angina and the acute coronary syndromes. The vascular endothelium plays a critical role in modulating both the inflammatory response and vasomotor abnormalities that occur in those with coronary artery disease or risk factors for disease. In these conditions, endothelial cells are activated by cytokines to express cellular adhesion molecules that facilitate the adhesion of leukocytes to the endothelium, and their migration into the subintimal space. Cytokines stimulate inflammatory and smooth muscle cells in the intima to produce degradative enzymes, including metalloproteinases that can weaken the fibrous cap of atherosclerotic lesions and make them vulnerable to rupture. Endothelial cells also regulate vascular tone by the synthesis of nitric oxide. Atherosclerosis and other conventional risk factors for coronary artery disease are associated with endothelial vasodilator dysfunction in the coronary epicardial and resistance vessels, which likely contributes to myocardial ischemia. Several studies have demonstrated that lowering serum total and LDL cholesterol reverses endothelial vasomotor dysfunction, reduces myocardial ischemia, and lowers the risk of the acute coronary syndromes or need for revascularization. Improving endothelial function, for example, by lowering blood cholesterol should now be regarded as a goal of therapy in the treatment of coronary artery disease.